Hoth Therapeutics, Inc. (HOTH)
NASDAQ: HOTH · Real-Time Price · USD
1.040
-0.040 (-3.70%)
Jan 16, 2026, 4:00 PM EST - Market closed
Hoth Therapeutics Market Cap
Hoth Therapeutics has a market cap or net worth of $16.13 million as of January 16, 2026. Its market cap has increased by 180.10% in one year.
Market Cap
16.13M
Enterprise Value
8.30M
1-Year Change
180.10%
Ranking
Category
Stock Price
$1.04
Market Cap Chart
Since February 15, 2019, Hoth Therapeutics's market cap has decreased from $80.39M to $16.13M, a decrease of -79.93%. That is a compound annual growth rate of -20.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 16.13M | 5.05% |
| Dec 31, 2025 | 15.36M | 166.64% |
| Dec 31, 2024 | 5.76M | -7.96% |
| Dec 29, 2023 | 6.26M | -38.29% |
| Dec 30, 2022 | 10.14M | -35.89% |
| Dec 31, 2021 | 15.82M | -50.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 15, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |